Skip to Content

OT-730 Approval Status

  • FDA approved: No
  • Brand name: OT-730
  • Company: Othera Pharmaceuticals, Inc.
  • Treatment for: Glaucoma

OT-730 is an oculoselective beta-blocker under review as a potential treatment for glaucoma.

Development Status and FDA Approval Process for OT-730

Aug  7, 2008Othera Files IND Application for OT-730 in Glaucoma

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.